Cashu | News | NTLA

HomeWatchlistNewsSignalsPicks

DJI

+0.53%

SPX

+0.32%

IXIC

+0.25%

FTSE

+0.49%

N225

+0.60%

AXJO

+0.90%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Intellia Therapeutics News

FDA Approves KalVista's Ekterly As First Oral On-Demand Treatment For Rare Swelling Disease

Feature Image for interests on Biotech, Briefs, Healthcare, News from benzinga.com

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering

Feature Image for interests on Biotech, Briefs, China, Fda from benzinga.com

Assessing Intellia Therapeutics: Insights From 9 Financial Analysts

about 1 month ago

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration

Feature Image for interests on Ark Invest, Ark Invest Management, Benzinga Neuro, Cathie Wood from benzinga.com

about 2 months ago

Demystifying Intellia Therapeutics: Insights From 9 Analyst Reviews

about 2 months ago

Cathie Wood Bets Against Mark Zuckerberg's Meta Ahead Of Crucial Earnings Report, Loads Up On This Amazon Rival

Feature Image for interests on Amd, Ark Invest Etfs, Ark Trades, Arkk from benzinga.com

Levi & Korsinsky Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline

Feature Image for interests on Healthcare, Levi & Korsinsky, Llp, Stock from prnewswire.com

businesswire.com

Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Feature Image for interests on Healthcare, Stock from businesswire.com

businesswire.com

Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Feature Image for interests on Healthcare, Stock from businesswire.com

businesswire.com

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stocks

Health Care

ntla

Intellia Therapeutics

NTLA

+0.49 (+4.27%)

11.97

USD

At close at Jul 16, 20:41 UTC

Latest Cashu News

Intellia Therapeutics and KalVista: Advancements in Hereditary Angioedema Treatment with KALV Ekterly

Intellia Therapeutics: KalVista Pharmaceuticals Launches KALV Ekterly for Hereditary Angioedema Treatment

Intellia Therapeutics Under Ethical Scrutiny Amid FDA Review of Genetic Engineering Trials